367 related articles for article (PubMed ID: 11231543)
1. The end of the beginning for genomic medicine.
Bailey D; Zanders E; Dean P
Nat Biotechnol; 2001 Mar; 19(3):207-9. PubMed ID: 11231543
[No Abstract] [Full Text] [Related]
2. A cold dose of medicine.
Nat Biotechnol; 2001 Mar; 19(3):181. PubMed ID: 11231513
[No Abstract] [Full Text] [Related]
3. Structural genomics in the biotechnology sector.
Dry S; McCarthy S; Harris T
Nat Struct Biol; 2000 Nov; 7 Suppl():946-9. PubMed ID: 11103995
[TBL] [Abstract][Full Text] [Related]
4. [Will genes become an engine to the industry?].
Nylund S; Sibakov M
Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
[No Abstract] [Full Text] [Related]
5. [Potential role of regulatory science in the development of novel biologics].
Hayakawa T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2003; (121):128-43. PubMed ID: 14740420
[No Abstract] [Full Text] [Related]
6. Microarray technology: an array of opportunities.
Gershon D
Nature; 2002 Apr; 416(6883):885-91. PubMed ID: 11976691
[No Abstract] [Full Text] [Related]
7. Bioinformatics in the pharmaceutical industry.
Lyall A
Trends Biotechnol; 1996 Aug; 14(8):308-12. PubMed ID: 8987464
[TBL] [Abstract][Full Text] [Related]
8. Companies of all sizes are prospecting for proteins.
Gavaghan H
Nature; 2000 Apr; 404(6778):684-6. PubMed ID: 10766256
[No Abstract] [Full Text] [Related]
9. New mouse site links researchers.
SoRelle R
Circulation; 2000 Oct; 102(18):E9036-7. PubMed ID: 11184629
[No Abstract] [Full Text] [Related]
10. Genomics. Medicine's future in our molecules.
Larson L
Trustee; 2000 Jan; 53(1):8-12, 1. PubMed ID: 11785218
[TBL] [Abstract][Full Text] [Related]
11. The impact of bacteriophage genomics.
McGrath S; Fitzgerald GF; van Sinderen D
Curr Opin Biotechnol; 2004 Apr; 15(2):94-9. PubMed ID: 15081045
[TBL] [Abstract][Full Text] [Related]
12. The use of genomics in clinical trial design.
Simon R
Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
[TBL] [Abstract][Full Text] [Related]
13. Patent protection for protein structure analysis.
Shimbo I; Nakajima R; Yokoyama S; Sumikura K
Nat Biotechnol; 2004 Jan; 22(1):109-12. PubMed ID: 14704710
[TBL] [Abstract][Full Text] [Related]
14. Arnold Demain.
Demain A
Nat Biotechnol; 2011 Mar; 29(3):193. PubMed ID: 21390012
[No Abstract] [Full Text] [Related]
15. [Movements on the systems biology in the post-genome era: from genome, gene and protein analysis to biosystems analysis].
Yao T
Tanpakushitsu Kakusan Koso; 2002 Jul; 47(9):1229-35. PubMed ID: 12166069
[No Abstract] [Full Text] [Related]
16. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
Hasetine W
Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
[No Abstract] [Full Text] [Related]
17. Free genome databases finally defeat Celera.
Marris E
Nature; 2005 May; 435(7038):6. PubMed ID: 15874985
[No Abstract] [Full Text] [Related]
18. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
19. Applying technologies towards safe and effective medicines.
Roses AD
Biotechniques; 2005 Oct; 39(4):563-4. PubMed ID: 16235568
[No Abstract] [Full Text] [Related]
20. Will genomics revolutionise pharmaceutical R&D?
Noble D
Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
